Comparison of five regimens for oral administration of medication to induce sedation in dogs prior to euthanasia.
To compare regimens for oral administration of medication to induce sedation in dogs prior to euthanasia. Prospective randomized clinical study. 37 dogs. Groups and medications were as follows: group 1, acepromazine (n = 8); group 2, tiletamine-zolazepam (8); group 3, tiletamine-zolazepam and acepromazine (8); group 4, tiletamine-zolazepam and butorphanol (6); and group 5, pentobarbital sodium (7). Capsules or tablets were placed in each dog's food. Sedation was scored at 3-minute intervals after consumption of medication for at least 60 minutes. Dogs with signs of persistent or progressive sedation were observed for 90 minutes. Only 2 dogs in group 1 became slightly ataxic. All group-2 dogs were slightly ataxic, and 4 of 8 became laterally recumbent (mean time to lateral recumbency, 62 minutes). Seven of 8 group-3 dogs became sternally recumbent, and 6 of these dogs became laterally recumbent (mean, 48.6 minutes). Four of 6 group-4 dogs were slightly or moderately ataxic, and 1 of these dogs became laterally recumbent (mean, 48 minutes). One dog in group 5 was not affected by the medication, but all other group-5 dogs became laterally recumbent (mean, 59 minutes). Of the medications evaluated, tiletamine-zolazepam and acepromazine at dosages of approximately 20 mg/kg (9.1 mg/lb) and 2 mg/kg (0.91 mg/lb), respectively, or pentobarbital sodium alone (63.2 +/- 5.1 mg/kg [28.7 +/- 2.3 mg/lb]) most consistently induced profound sedation and lateral recumbency after oral administration to dogs.